US Health and Human Services (HHS) Secretary Xavier Becerra said the agency has recommended that marijuana be changed from a "Schedule I" to a "Schedule III". This would ease restrictions and reduce or eliminate criminal penalties associated with marijuana. It also opens the door potential legalization by states that prohibit it.

What's the difference?
Schedule I drugs – "have NO CURRENTLY ACCEPTED MEDICAL USE in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse."

Schedule III drugs – “have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.”

https://www.reuters.com/business/healthcare-pharmaceuticals/hhs-official-calls-move-marijuana-lower-risk-drug-category-bloomberg-news-2023-08-30/

Medical use? (Repost)
https://kolektiva.social/@OutOfExile_IDR_Voice/109645282996256325

#NaturesPharmaceutical #cannabis #neuroprotectant #antioxidant #disability #mmj

“Cannabis,  Alzheimers, TBI and Invisible Disability"

Click here 🧠 to expand.

Cannabis can still be a controversial topic. The medical benefits for those with physical and invisible disabilities are no secret. People with Invisible disabilities, such as brain injury and PTSD, can be afforded great relief from symptoms by the flower.

Israeli Dr. Raphael Mechoulam, is a well known cannabis research pioneer who has been studying the plant for decades. Read about some of his work in the link below.

Other Research indicates that individuals living with Alzheimers and Dementia may also benefit with less risk and damaging effects than other drugs currently used. 

Findings from another Israeli Researcher, Dedi Meiri, argue that there may be benefits to these individuals as well.

"There is a large and growing body of anecdotal accounts of the efficacy of cannabis for treating the symptoms of Alzheimer’s disease and dementia. The shortcomings ... life-threatening dangers...with... frequently prescribed pharmaceutical treatments... makes cannabis a particularly compelling option – especially considering its solid safety profile."

Even more research from the National Library of Medicine (PubMed.gov), speaks about the neuroprotectant antioxidant qualities of the herb. The PubMed link below contains several links to other studies on cannabis and it’s benefits for people with disabilities.

The human body is said to have CBD receptors "built" in. I am neither condoning, nor condemning the use of “Natures Pharmaceutical"; nor am I suggesting it's use. I am merely presenting medical findings.

According to laws in many places amidst these findings, the jury is still out on the subject.

MedGov:
https://pubmed.ncbi.nlm.nih.gov/10863546/

Dr. Mechoulam:
https://www.nbcnews.com/tech/innovation/cannabis-research-pioneer-hopes-latest-discovery-not-overlooked-again-n1059116

Alzheimers:
https://www.forbes.com/sites/abbierosner/2020/06/18/notes-from-the-cutting-edge-israeli-researcher-dedi-meiri-on-cannabis-alzheimers-and-dementia/

On regeneration and prevention ofAlzheimers:
https://www.cryptosavvy.com/2018/09/cannabis-regenerate-aging-brain-dementia.html

On reversing aging:
https://dailyhealthpost.com/cannabis-reverses-aging-processes-in-the-brain/

Image courtesy of:
https://merryjane.com/culture/heres-how-scientists-think-cannabis-can-repair-brain-cells-and-improve-memory

#RaphaelMechoulam #CannabisResearch #Pain #Relief #neuroprotectant #antioxidant #InvisibleDisability #disability #MentalHealth #anxiety #CBD #CbdReceptors #THC #TBI #alzheimers #PTSD #BrainInjury #SpineInjury #cannabis #flower #herb #Truth #KanehBosem #biblical #pot #TheDevilsParsley #ganja #NaturesPharmaceutical #InvisibleDisabilityRights

Originally posted Dec 04, 2022, 02:15 by OutOfExile_IDR

This is an actual 2006 election billboard that encouraged Colorado voters to legalize the "Devil's Parsley", aka cannabis.

Achtung:
Don't drink and hunt... or try to run a government.

Don't operate heavy legislation while under the influence of alcohol.

#humor #sarcasm #DickCheney #GeorgeDub #MedicinalHumor #sarcasm #NaturesPharmaceutical #cannabis #mmj acts as a #neuroprotectant according to PubMed.gov #DisabilitySolidarity #BlueCrew

Adenosine has a wide range of clinical applications & it is used to treat a variety of conditions such as supraventricular #tachycardia and #AtrialFibrillation, chronic ischemic heart disease, #sleep disorders, and #stroke. Adenosine is also being studied in the treatment of neurodegenerative diseases, cancer, and #age-related diseases, and is being used as a #neuroprotectant agent. Adenosine is a promising agent in the development of #therapeutic strategies for a wide range range of conditions.

1of2
Cannabis can still be a controversial topic. The medical benefits for those with physical and invisible disabilities are no secret. People with Invisible disabilities such as #braininjury and #PTSD, can be afforded great relief from symptoms by the #flower.

Israeli Dr. Raphael Mechoulam is a well known #cannabis research pioneer who has been studying the plant for decades. Read about some of his work in the link below.

Other Research indicates that individuals living with Alzheimers and Dementia may also benefit with less risk than other drugs currently used.

Findings from another Israeli Researcher, Dedi Meiri, argue that there may be benefits to these individuals as well.

"There is a large and growing body of anecdotal accounts of the efficacy of cannabis for treating the symptoms of Alzheimer’s disease and dementia. The shortcomings ... life-threatening dangers...with... frequently prescribed pharmaceutical treatments... makes cannabis a particularly compelling option – especially considering its solid safety profile."

Even more research from the National Library of Medicine (PubMed.gov), speaks about the #neuroprotectant #antioxidant qualities of the #herb. The link below contains several links to others studies on cannabis and the relief for with people with #disabilities.

The human body is said to have CBD receptors "built" in. I am neither condoning, nor condemning the use of #NaturesPharmaceutical; nor am I suggesting it's use. I am merely presenting medical findings.

The little graphic I created below a few years ago, also is not an indication of support or use. According to laws in many places amidst these findings, the jury is still out.😉

MedGov:
https://pubmed.ncbi.nlm.nih.gov/10863546/

Dr. Mechoulam:
https://www.nbcnews.com/tech/innovation/cannabis-research-pioneer-hopes-latest-discovery-not-overlooked-again-n1059116

Alzheimers:
https://www.forbes.com/sites/abbierosner/2020/06/18/notes-from-the-cutting-edge-israeli-researcher-dedi-meiri-on-cannabis-alzheimers-and-dementia/

#RaphaelMechoulam #CannabisResearch #Pain Relief #InvisibleDisability #disability #MentalHealth #anxiety #CBD #CbdReceptors #THC

Main:
@OutOfExile_IDR@disabled.social